Skip to content

EBIT at other companies

IAR
Integra LifeSciencesIART
$11.47M+174%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$14.44M+70.5%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.48M-37.6%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Stryker logo
StrykerSYK
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Calculated from Sanara MedTech Inc.’s reported figures.

Plus components not separately reported this period.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s EBIT?
Sanara MedTech Inc. (SMTI) reported EBIT of $2.65M in Q1 2026.
How has Sanara MedTech Inc.'s EBIT changed year-over-year?
Sanara MedTech Inc.'s EBIT increased by 220.6% year-over-year, from $825.53K to $2.65M.
What is the long-term trend for Sanara MedTech Inc.'s EBIT?
Over 4 years (2021 to 2025), Sanara MedTech Inc.'s EBIT has grown at a -10.3% compound annual growth rate (CAGR), from -$7.38M to $4.79M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.